Special Round Table (Importance of Strong Drug Regulatory Systems)–3rd Nov, 2015
Ali Mehdi
Wednesday, 9th March 2016
KG Marg, New Delhi 110003

In order to launch the second phase of its Research Program on Drug Regulatory Reforms in India, ICRIER organized a Special Roundtable on the ‘Importance of Strong Drug Regulatory Systems’ at New Delhi on November 3, 2015. The goal of this roundtable was to discuss and deliberate upon the following upcoming themes under the research program viz. Clinical trials and new drug approvals and Harmonization of certification standards.

The roundtable began with the Inaugural Address by Dr S Eswara Reddy, Joint Drugs Controller (India), CDSCO, Government of India, followed by a Special Address by Mr Kenneth C Frazier, Chairman and CEO, Merck, USA. The distinguished panelists at the roundtable included Dr Kiran Mazumdar-Shaw, Chairperson and Managing Director, Biocon, Bengaluru; Dr Y K Gupta, Professor & Head, Department of Pharmacology, AIIMS, New Delhi; Dr Samir Brahmachari, Chief Mentor, Open Source Drug Discovery; Former Director General, Council of Scientific and Industrial Research (CSIR), New Delhi; Dr Hemant Koshia, Commissioner, Food and Drugs Control Administration, Gujarat and Dr Ratna Devi, CEO, Dakshama Health, New Delhi.

List of partcipants-

1.Ali Mehdi
2.Sanchita Sinha
3.Priyanka Tomar

S.no Name Position City Contact no.
1 Ali Mehdi FELLOW Delhi 9999999999
2 Pallavi Joshi Research Associate Delhi 9999999999
3 Priyanka Tomar Research Assistant Delhi 9999999999
4 Sanchita Sinha Consulting Editor Delhi 9999999999